Atlas Trials

Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.

Clinical trial NCT02806414 · COMPLETED

Trial details

NCT number
NCT02806414
Sponsor
University of California, San Diego
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rosacea
Start date
2016-07-01
Primary completion
2019-07-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.